The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive ...

Migraine disease affects millions of Americans, but treatments often cause side effects that hinder sufferers' ability to function.

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged.

The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

recommendations are presented for the pharmacologic treatment of acute episodic migraine headache in the outpatient setting. Amir Qaseem, MD, PhD, from the ACP in Philadelphia, and colleagues ...

Delivering room-temperature air through the nose to cool the sphenopalatine ganglion taps into a powerful neuromodulatory ...

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

Migraines last anywhere between four and 72 hours to days, depending on the intensity of symptoms. Learn how long acute and ...

ACP also provides guidance to clinicians to consider counseling nonpregnant adults to begin treatment for acute migraine headache as soon as possible after its onset by utilizing combination ...

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

Compared with sham, transnasal dry air flow at 10 L per minute using the Mi-Helper device was effective in treating acute ...

Acute treatments are used to provide headache relief during a migraine episode, and the current treatment landscape is highly competitive. Oral triptans are considered the industry gold standard ...